D
Deborah Donnell
Researcher at Fred Hutchinson Cancer Research Center
Publications - 231
Citations - 13344
Deborah Donnell is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Pre-exposure prophylaxis & Population. The author has an hindex of 49, co-authored 199 publications receiving 11097 citations. Previous affiliations of Deborah Donnell include University of California, Los Angeles & University of Washington.
Papers
More filters
Journal ArticleDOI
Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 Study
Wafaa El-Sadr,Geetha Beauchamp,H. Irene Hall,Lucia V. Torian,Barry S. Zingman,Garret Lum,Richard Elion,Kate Buchacz,David N. Burns,Allison Zerbe,Theresa Gamble,Deborah Donnell,Hptn Study +12 more
TL;DR: The HPTN 065 study showed that financial incentives (FI) were associated with significantly higher viral load suppression and higher levels of engagement in care among patients at HIV care sites randomized to FI versus sites randomized in standard of care (SOC) as mentioned in this paper.
Journal ArticleDOI
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.
Anne F Luetkemeyer,Deborah Donnell,Julia C. Dombrowski,Stephanie E. Cohen,Cole Grabow,Clare E. Brown,Cheryl Malinski,C. Cimadevilla López,Eric Vittinghoff,Susan Buchbinder,Hyman M. Scott,Edwin D. Charlebois,Diane V. Havlir,Olusegun O. Soge,Connie Celum +14 more
TL;DR: In this article , the authors conducted an open-label, randomized study involving men who have sex with men (MSM) and transgender women who were taking preexposure prophylaxis (PrEP) against human immunodeficiency virus (HIV) infection and living with HIV infection, and who had had Neisseria gonorrhoeae (gonorrhea), Chlamydia trachomatis (chlamydia), or syphilis in the past year.
Outcomes from NIMH Project Accept (HPTN 043): a cluster-randomized trial of community mobilization, mobile HIV testing, post-test support services, and real-time performance feedback
Thomas J. Coates,Michal Kulich,Carla E. Zelaya,David D. Celentano,Suwat Chariyalertsak,Alfred Chingono,Glenda Gray,Jessie Mbwambo,Steve Morin,Linda Richter,Michael D. Sweat,H. Van Rooyen,Nuala McGrath,Agnès Fiamma,Oliver Laeyendecker,Estelle Piwowar-Manning,Greg Szekeres,Deborah Donnell,S. Eshelman +18 more
Journal ArticleDOI
Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression.
James R Moore,James R Moore,Deborah Donnell,Marie-Claude Boily,Kate M Mitchell,Sinead Delany-Moretlwe,Linda-Gail Bekker,Nyaradzo Mgodi,Wafaa El-Sadr,Myron S. Cohen,Connie Celum,Dobromir T. Dimitrov,Dobromir T. Dimitrov,Dobromir T. Dimitrov +13 more
TL;DR: The potential of the proposed methodology to provide HIV incidence predictions based on assessment of individual risk behaviors and community and time-specific HIV exposure risk using HIV treatment and viral suppression data may serve as comparators in HIV prevention trials without a placebo group.
Journal ArticleDOI
Predicted Effectiveness of Daily and Nondaily Preexposure Prophylaxis for Men Who Have Sex With Men Based on Sex and Pill-taking Patterns From the Human Immuno Virus Prevention Trials Network 067/ADAPT Study
Dobromir T. Dimitrov,Dobromir T. Dimitrov,James R Moore,Daniel T. Wood,Kate M. Mitchell,Maoji Li,James P. Hughes,James P. Hughes,Deborah Donnell,Sharon Mannheimer,Timothy H. Holtz,Robert M. Grant,Marie-Claude Boily +12 more
TL;DR: PrEP was more effective among MSM in Thailand than in the United States as a result of more fully covered sex acts and more pills taken around partially covered acts and nondaily PrEP was less effective than daily PrEP.